Clicky

Genetic Signatures Ltd  (GSS)

Description: Genetic Signatures Limited is a molecular diagnostics company. The Company is engaged in the research and commercialization of identifying individual genetic signature to identify diseases and disabilities, and the sale of associated products into diagnostic and research market place. It is focused on the development and commercialization of its platform technology, 3Base. The Company has a suite of polymerase chain reaction (PCR)-based products for the detection of infectious diseases under the EasyScreen brand. Its product portfolio includes EasyScreen detection kits and MethylEasy research kits. The Company's 3base technology forms the basis of its EasyScreen Pathogen Detection Kits. Its EasyScreen products provide hospital and pathology laboratories with the molecular tools to screen for an array of infectious pathogens. Its MethylEasy research kits include Methyl Easy Xceed, which is a bisulfite modification research kit for the detection of methylation patterns in genes.


Keywords: Biotechnology Biology Disease Infectious Diseases Molecular Biology Hospital Molecular Diagnostics Laboratory Techniques Pathology Platform Technology Polymerase Chain Reaction Qiagen Easy

Home Page: www.geneticsignatures.com

GSS Technical Analysis

Heart Research Institute
Newtown, NSW 2042
Australia
Phone: 61 2 9870 7580


Officers

Name Title
Dr. John R. Melki BSc, Ph.D. MD, CEO & Exec. Director
Mr. Peter L. Manley CPA CFO & Company Sec.
Mr. Michael Anton Aicher BSc, M.B.A., MBA Exec. Director of US Operations & Exec. Director
Mr. Christopher M. Abbott Founder & Chairman Emeritus
Dr. Douglas S. Millar BSc, Ph.D. Chief Scientific Officer
Ms. Neralie Coulston B.Sc. Global Head of Regulatory Affairs
Mr. Jackson Jones B.Sc. Chief Commercial Officer

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 54.9451
Trailing PE: 42.99
Price-to-Book MRQ: 2.2505
Price-to-Sales TTM: 3.5755
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks